<DOC>
	<DOCNO>NCT00682097</DOCNO>
	<brief_summary>This study evaluate safety , tolerability , pharmacokinetics pharmacodynamics multiple ascend dos RO4998452 compare placebo patient type 2 diabetes mellitus . Successive cohort patient randomize receive either active drug , escalate dos , placebo . The anticipated time study treatment &lt; 3 month , target sample size &lt; 100 individual .</brief_summary>
	<brief_title>A Multiple Ascending Dose Study RO4998452 Patients With Type 2 Diabetes Mellitus .</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>adult patient , 1865 year age ; type 2 diabetes ; either treat diet exercise alone metformin . type 1 diabetes mellitus ; uncontrolled hypertension ; clinically severe diabetic complication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>